In the 1980s, Dr. Steven Rosenberg at the National Cancer Institute (NCI) conducted clinical trials in which they administered high doses of IL-2 to patients with advanced cancer, leading to partial or even complete remission of their tumors (12). The gene discussed is IL2; the disease is cancer.